
\begin{longtable}[t]{lccc}
\caption{\label{tab:sus_characteristics}Characteristics of the study population compared with all people hospital-onset COVID-19, and all people with PCR-confirmed community-acquired COVID-19 in England.}\\
\toprule
\textbf{Characteristic} & \makecell[c]{\textbf{Study population}\ \ \\ \textbf{(hospitalised for}\ \ \\ \textbf{COVID-19}\ \ \\ \textbf{in England)}\ \ \\N = 590,313} & \makecell[c]{\textbf{All people with}\ \ \\ \textbf{hospital-onset}\ \ \\ \textbf{COVID-19}\ \ \\ \textbf{in England}\ \ \\N = 209,139} & \makecell[c]{\textbf{All people with}\ \ \\ \textbf{PCR-confirmed,}\ \ \\ \textbf{community-acquired}\ \ \\ \textbf{COVID-19 in England}\ \ \\N = 6,617,362}\\
\midrule
Age group &  &  & \\
\hspace{1em}0--14 & 19,186 (3.3\%) & 2,635 (1.3\%) & 892,380 (13\%)\\
\hspace{1em}15--24 & 28,936 (4.9\%) & 4,437 (2.1\%) & 1,264,528 (19\%)\\
\hspace{1em}25--44 & 122,390 (21\%) & 13,764 (6.6\%) & 2,244,393 (34\%)\\
\hspace{1em}45--64 & 154,594 (26\%) & 33,209 (16\%) & 1,560,517 (24\%)\\
\hspace{1em}65--74 & 90,037 (15\%) & 36,537 (17\%) & 301,440 (4.6\%)\\
\hspace{1em}75--84 & 101,578 (17\%) & 59,892 (29\%) & 198,209 (3.0\%)\\
\hspace{1em}85+ & 73,592 (12\%) & 58,665 (28\%) & 155,895 (2.4\%)\\
Sex &  &  & \\
\hspace{1em}Male & 289,085 (49\%) & 108,709 (52\%) & 3,152,281 (48\%)\\
\hspace{1em}Female & 301,228 (51\%) & 100,430 (48\%) & 3,465,081 (52\%)\\
Ethnicity &  &  & \\
\hspace{1em}White & 444,615 (75\%) & 185,426 (89\%) & 5,100,779 (77\%)\\
\hspace{1em}Asian & 58,411 (9.9\%) & 9,877 (4.7\%) & 740,301 (11\%)\\
\hspace{1em}Black & 33,961 (5.8\%) & 6,362 (3.0\%) & 278,844 (4.2\%)\\
\hspace{1em}Mixed/Other/Unknown & 41,386 (7.0\%) & 7,474 (3.6\%) & 497,438 (7.5\%)\\
\hspace{1em}Prefer not to say & 11,940 (2.0\%) & 0 (0\%) & 0 (0\%)\\
Region of residence &  &  & \\
\hspace{1em}London & 104,850 (18\%) & 28,779 (14\%) & 1,078,524 (16\%)\\
\hspace{1em}East Midlands & 51,147 (8.7\%) & 18,774 (9.0\%) & 586,490 (8.9\%)\\
\hspace{1em}East of England & 59,735 (10\%) & 22,809 (11\%) & 679,080 (10\%)\\
\hspace{1em}North East & 33,809 (5.7\%) & 9,416 (4.5\%) & 376,501 (5.7\%)\\
\hspace{1em}North West & 94,658 (16\%) & 42,276 (20\%) & 1,056,101 (16\%)\\
\hspace{1em}South East & 76,913 (13\%) & 28,819 (14\%) & 887,347 (13\%)\\
\hspace{1em}South West & 48,448 (8.2\%) & 12,880 (6.2\%) & 496,337 (7.5\%)\\
\hspace{1em}West Midlands & 66,495 (11\%) & 24,544 (12\%) & 733,204 (11\%)\\
\hspace{1em}Yorkshire and Humber & 54,258 (9.2\%) & 20,842 (10.0\%) & 723,778 (11\%)\\
\multicolumn{3}{l}{Index of Multiple Deprivation}  & \\
\hspace{1em}Most deprived & 159,904 (27\%) & 51,314 (25\%) & 1,564,566 (24\%)\\
\hspace{1em}2nd quintile & 133,835 (23\%) & 44,996 (22\%) & 1,440,738 (22\%)\\
\hspace{1em}3rd quintile & 111,840 (19\%) & 40,584 (19\%) & 1,288,334 (19\%)\\
\hspace{1em}4th quintile & 99,313 (17\%) & 38,418 (18\%) & 1,210,037 (18\%)\\
\hspace{1em}Least deprived & 85,421 (14\%) & 33,827 (16\%) & 1,113,687 (17\%)\\
Hospital outcome &  &  & \\
\hspace{1em}Death & 81,343 (14\%) & 69,469 (33\%) & -\\
\hspace{1em}Discharge & 507,254 (86\%) & 107,878 (52\%) & -\\
\hspace{1em}Right-censored in hospital & 1,716 (0.3\%) & 31,792 (15\%) & -\\
Month of hospital admission &  &  & \\
\hspace{1em}Mar 2020 & 18,285 (3.1\%) & - & -\\
\hspace{1em}Apr 2020 & 36,524 (6.2\%) & - & -\\
\hspace{1em}May 2020 & 10,471 (1.8\%) & - & -\\
\hspace{1em}Jun 2020 & 3,826 (0.6\%) & - & -\\
\hspace{1em}Jul 2020 & 1,506 (0.3\%) & - & -\\
\hspace{1em}Aug 2020 & 1,276 (0.2\%) & - & -\\
\hspace{1em}Sep 2020 & 5,175 (0.9\%) & - & -\\
\hspace{1em}Oct 2020 & 19,525 (3.3\%) & - & -\\
\hspace{1em}Nov 2020 & 29,932 (5.1\%) & - & -\\
\hspace{1em}Dec 2020 & 40,657 (6.9\%) & - & -\\
\hspace{1em}Jan 2021 & 77,186 (13\%) & - & -\\
\hspace{1em}Feb 2021 & 25,488 (4.3\%) & - & -\\
\hspace{1em}Mar 2021 & 7,941 (1.3\%) & - & -\\
\hspace{1em}Apr 2021 & 3,100 (0.5\%) & - & -\\
\hspace{1em}May 2021 & 2,260 (0.4\%) & - & -\\
\hspace{1em}Jun 2021 & 5,597 (0.9\%) & - & -\\
\hspace{1em}Jul 2021 & 20,340 (3.4\%) & - & -\\
\hspace{1em}Aug 2021 & 22,388 (3.8\%) & - & -\\
\hspace{1em}Sep 2021 & 19,510 (3.3\%) & - & -\\
\hspace{1em}Oct 2021 & 21,974 (3.7\%) & - & -\\
\hspace{1em}Nov 2021 & 20,707 (3.5\%) & - & -\\
\hspace{1em}Dec 2021 & 31,716 (5.4\%) & - & -\\
\hspace{1em}Jan 2022 & 54,310 (9.2\%) & - & -\\
\hspace{1em}Feb 2022 & 28,412 (4.8\%) & - & -\\
\hspace{1em}Mar 2022 & 42,885 (7.3\%) & - & -\\
\hspace{1em}Apr 2022 & 39,322 (6.7\%) & - & -\\
\multicolumn{3}{l}{Vaccination status at date of admission (January 2021 onwards)}  & \\
\hspace{1em}Unvaccinated & 367,082 (62\%) & - & -\\
\hspace{1em}<21 days after first dose & 14,385 (2.4\%) & - & -\\
\hspace{1em}$\leq$21 days after first dose & 20,711 (3.5\%) & - & -\\
\hspace{1em}$\geq$14 days after second dose & 119,559 (20\%) & - & -\\
\hspace{1em}$\geq$14 days after third dose & 68,576 (12\%) & - & -\\
Charlson comorbidity index &  &  & \\
\hspace{1em}0 & 232,646 (39\%) & - & -\\
\hspace{1em}1-2 & 227,174 (38\%) & - & -\\
\hspace{1em}3-4 & 85,131 (14\%) & - & -\\
\hspace{1em}5+ & 45,362 (7.7\%) & - & -\\
\multicolumn{3}{l}{Hospital load at time of admission (as proportion of busiest week)}  & \\
\hspace{1em}0-20\% & 120,259 (20\%) & - & -\\
\hspace{1em}20-40\% & 192,060 (33\%) & - & -\\
\hspace{1em}40-60\% & 123,943 (21\%) & - & -\\
\hspace{1em}60-80\% & 80,567 (14\%) & - & -\\
\hspace{1em}80-90\% & 34,308 (5.8\%) & - & -\\
\hspace{1em}90-100\% & 39,176 (6.6\%) & - & -\\
\bottomrule
\end{longtable}
